We did not include other biological (such as coronary calcium or C-reactive protein) or behavioral (such as obesity or exercise) risk factors because none are included in Framingham risk scoring currently used in cholesterol risk stratification and treatment guidelines. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.